v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04648800 |
Full text link
Last imported at : Dec. 3, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : Dec. 3, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : Dec. 3, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
prorektor.cm@ur.edu.pl |
Registration date
Last imported at : Dec. 3, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
2020-12-02 |
Recruitment status
Last imported at : Nov. 7, 2022, noon Source : ClinicalTrials.gov |
Unknown |
Study design
Last imported at : Dec. 3, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Dec. 3, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Dec. 3, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Dec. 3, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
Blind label |
Center
Last imported at : Dec. 3, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
multi-center |
Study aim
Last imported at : Dec. 3, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
Prevention |
Inclusion criteria
Last imported at : Dec. 3, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
inclusion criteria: - a health care professional (physician, nurse, midwife, paramedic, electroradiology technician, laboratory diagnostician, physiotherapist, nutritionist, orderly) aged >25 years - no confirmed sars-cov-2 infection - informed consent to participate in the trial and consent to personal data processing - declared availability for telephone contacts throughout the study period - good health condition - earlier vaccination against tuberculosis |
Exclusion criteria
Last imported at : Dec. 3, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
- hypersensitivity to any component of bcg-10 - hypersensitivity to previously administered tuberculin (local skin lesions, necrosis of the skin, blisters, other severe skin reactions at the injection site) - hiv infection (confirmed or suspected infections, even if they are asymptomatic) - primary or secondary immunodeficiencies (including interferon - gamma deficiency or digeorge syndrome) - radiotherapy (less than 24 months before the date of inclusion in the trial - treatment with corticosteroids, ongoing immunosuppressive therapy (including those treated with monoclonal antibodies to tnf-α, such as infliximab) - less than 24 months before the date of inclusion in the trial - neoplastic diseases (e.g. leukaemia, malignant granuloma, lymphoma or some other cancer of the reticuloendothelial system) - less than 24 months before the date of inclusion in the study - after stem cell transplantation and organ transplantation - in the exacerbation stage of chronic diseases (including severe malnutrition) - pregnancy - history of tuberculosis - keloid at the vaccination site after previous bcg vaccination |
Number of arms
Last imported at : Dec. 3, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
3 |
Funding
Last imported at : Dec. 3, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
Hanna Czajka |
Inclusion age min
Last imported at : Dec. 3, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
25 |
Inclusion age max
Last imported at : Dec. 3, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
100 |
Countries
Last imported at : Dec. 3, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
Poland |
Type of patients
Last imported at : Dec. 3, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
Health workers |
Severity scale
Last imported at : Dec. 3, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
N/A |
Total sample size
Last imported at : Dec. 3, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
1000 |
primary outcome
Last imported at : Dec. 3, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
death and life- or health-threatening condition (cardiac arrest with effective resuscitation, shock, severe respiratory failure, severe renal failure, stroke/transient cerebral ischaemia) |
Notes
Last imported at : Dec. 3, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Feb. 25, 2021, 7:58 p.m. Source : ClinicalTrials.gov |
Phase 3 |
Arms
Last imported at : Dec. 3, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 186, "treatment_name": "Bcg vaccine", "treatment_type": "Non covid vaccine", "pharmacological_treatment": "Non covid vaccine"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}] |